Vascular endothelial injury is a serious complication and often leads to organ dysfunction after hematopoietic SCT (HSCT). Multiple factors, including acute GVHD, calcineurin inhibitors and infections, can contribute to the endothelial damage in posttransplant patients.
1,2 Because of similarities in histology, such vascular injury has been considered a member of thrombotic microangiopathy (TMA), including thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome. However, unlike other TMAs, post-transplant endothelial damage has rarely been associated with severe deficiency of ADAMTS13 and does not respond well to plasma exchange. 3 Thus, the 'post-transplant endothelial disorder (PTED)' has distinct features, and its pathophysiology remains uncertain.
To gain insights into the pathogenesis of PTED, we analyzed the clinical and pathologic data of 15 consecutive patients with HSCT autopsied at the University of Tokyo Hospital from 1995 to 2002 ( Table 1 ). During that time, 42 and 179 patients received autologous and allogeneic HSCT, respectively, in our hospital. Among them, 21 and 95 patients died, respectively. Autopsies were performed for cases that we got formal permissions from the bereaved family. An expert pathologist blinded to clinical data examined hematoxylin and eosin-stained sections of paraffinembedded autopsy tissues for histologic evidence of PTED. The histological features of PTED include myxoid intimal thickening, occluded vascular lumens, endothelial separation with swelling, fibrin deposition and necrosis that are essentially identical to those of classical TMAs (Figure 1a) . 4, 5 However, systemic thromboses are rarely seen in these post-transplant patients, in contrast to patients with TTP. Six (40%) of the 15 patients showed histologic evidence of PTED in small intestine (patient (pt.) 1 --5) or in kidney (pt. 1, 2, 6). There were 5 (33%) additional cases showing mild vascular changes only in kidney, and these cases were diagnosed as 'possible' PTED. Four (27%) patients showed no histologic evidence of PTED. Among the six patients with definite PTED, 4 (67%) patients were clinically diagnosed with TMA, but the other two patients (Pt. 2 and 5) were not. TMA was diagnosed by clinical findings including intravascular hemolysis associated with the detection of increased fragmented erythrocytes. None of the five patients with possible PTED were diagnosed with TMA after HSCT (Table 1) . Thus, some post-transplant patients did not show typical manifestations of TMA even with severe vascular injury. We speculate that severity and the primary site (intestine or kidney) of vascular damage affect clinical presentations of PTED patients. Larger studies will be needed to reveal the link between vascular injury and clinical manifestations in post-transplant patients.
To our surprise, all six patients with definite PTED experienced grade III-IV GVHD in their clinical course, whereas the other nine patients did not. Skin and gut GVHD were diagnosed by the clinical course and histologic examination of the affected area on the basis of the classical criteria. 6 Liver GVHD was diagnosed mainly by the clinical course. Given that the pathologist was blinded to clinical information, the exact match of patients with severe GVHD to those with PTED was striking, and it may suggest that GVHD is a primary cause of endothelial damage in these patients. 7 However, it should be noted that no patients with possible PTED experienced GVHD, indicating that the mild PTED is caused by other factors, such as calcineurin inhibitors. 8 In addition, 4 (67%) out of six definite PTED patients showed evidence of viral/fungal infection, suggesting that the infections also contributed to the development of PTED. However, evidence of infection was not specific to patients with PTED. For example, Pt. 12 was infected with BK virus, adenovirus and aspergillus, but showed no vascular damage. Hematologic relapse has no relation to PTED (Table 1) .
We have previously shown that peripheral blood erythroblastosis was associated with poor survival in HSCT recipients, and identified several potential etiologies for post-transplant erythroblastosis, including GVHD, TMA and hematologic relapse. 9 In this study, we found that the highest count of erythroblast (EBL, RBC retaining a nucleus) in the patients with definite PTED was significantly higher than that in patients without PTED (geometric mean value 653 vs 19, P ¼ 0.016, Figure 1b) . Furthermore, 4 (80%) patients with possible PTED also experienced erythroblastosis exceeding 100/mL (geometric mean value 209). In contrast, the EBL count was not affected by hematologic relapse in these autopsied cases (Figure 1b) . These results indicate that vascular injury is an important cause of erythroblastosis after HSCT.
In summary, our blinded autopsy study demonstrated close association between GVHD and PTED after HSCT. Peripheral blood erythroblastosis exceeding 100/mL may indicate vascular endothelial damage in post-transplant patients.
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